日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hemophagocytic Lymphohistiocytosis Associated with Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis of Spontaneous Reports

与免疫检查点抑制剂相关的噬血细胞性淋巴组织细胞增生症:自发报告的药物警戒分析

Guzel, Suleyman Sami; Tay, Kubilay; Cicek, Ebru; Jeral Evinc, Seda; Atak, Suheyla; Papila, Cigdem; Demirci, Nebi Serkan; Alan, Ozkan

Prognostic Impact of the Lung Immune Prognostic Index in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab

肺免疫预后指数对接受纳武利尤单抗治疗的转移性非小细胞肺癌患者的预后影响

Bedir, Şahin; Kapağan, Tanju; Bozkaya, Yakup; Oyman, Abdilkerim; Fidan, Mehmet Cem; Guliyev, Murad; Abbasov, Hamza; Demirci, Nebi Serkan; Yıldırım Doğan, Hale Gülçin; Çelik, Emir; Bulut, Nilüfer; Erdem, Gökmen Umut

Physics-guided machine learning framework for RCA concrete by experimental database, modelling, and statistical validation

基于实验数据库、建模和统计验证的物理引导机器学习框架在再生混凝土中的应用

Mohamud, Mohamed Abdikarin; Alasiri, Muhannad Riyadh; Özdöner, Nebi; Yıldızel, Sadık Alper; Özkılıç, Yasin Onuralp

Diagnostic utility and discriminative ability of cholesterol-modified prognostic nutritional index and inflammatory indicators in colorectal cancer: a retrospective case-control study

胆固醇修正预后营养指数和炎症指标在结直肠癌诊断中的应用价值和鉴别能力:一项回顾性病例对照研究

Papila, Berrin; Durmus, Sinem; Guliyev, Murad; Alan, Ozkan; Demirci, Nebi Serkan; Gelisgen, Remise; Papila, Cigdem; Uzun, Hafize

Capecitabine versus Paclitaxel After CDK4/6 Inhibitor Progression in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Real-World Study

卡培他滨对比紫杉醇治疗CDK4/6抑制剂治疗进展后激素受体阳性、HER2阴性转移性乳腺癌:一项真实世界研究

Birsin, Zeliha; Güren, Ali Kaan; Aliyev, Vali; Guliyev, Murad; Jeral, Seda; Cebeci, Selin; Çerme, Emir; Günaltılı, Murat; Abbasov, Hamza; Çiçek, Ebru; Atak, Süheyla; Sarı, Murat; Demirci, Nebi Serkan; Alan, Özkan

Lived experience and attitudes of esophageal cancer patients toward stenting-based care at Asella referral hospital: a qualitative exploration from a resource-limited setting in South-Eastern Ethiopia

阿塞拉转诊医院食管癌患者对支架置入治疗的亲身经历和态度:来自埃塞俄比亚东南部资源匮乏地区的定性探索

Adem, Jibril Bashir; Adilo, Abebe Megerso; Deybasso, Haji Aman; Kabeto, Muhammed; Alhur, Anas Ali; Nebi, Tewodros Desalegn; Dejene, Gadisa; Tekle, Mengesha Akale; Tarie, Jemal Reshad; Hamid, Mifta Dellil; Tiba, Melik; Lencho, Abashamo

Assessment of Meet-URO and CANLPH Prognostic Models in Metastatic RCC: Insights from a Single-Institution Cohort Predominantly Treated with TKIs

转移性肾细胞癌中 Meet-URO 和 CANLPH 预后模型的评估:来自主要接受 TKI 治疗的单中心队列的启示

Kuzu, Ömer Faruk; Karadurmuş, Nuri; Kanat, Nebi Batuhan; Özel Bozdağ, Dilruba İlayda; Karadurmuş, Berkan; Kaplan Tüzün, Esmanur; Atacan, Hüseyin; Mammadzada, Nurlan; Hafızoğlu, Emre; Yıldırım, Gizem; Aykan, Musa Barış; Bedir, Selahattin; Ertürk, İsmail

Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis

卵巢癌一线PARP抑制剂治疗的疗效:一项多中心回顾性分析

Koksal, Baris; Yildirim, Hasan Cagri; Guven, Deniz Can; Kose, Fatih; Koymen, Gorkem; Ozdemir, Ozlem; Ozberk, Ugur; Algin, Efnan; Guliyev, Murad; Demirci, Nebi Serkan; Alan, Ozkan; Baklaci, Ahmet; Demir, Bilgin; Topkaya, Ozlem; Uskent, Necdet; Yucel, Kadriye Bir; Akdogan, Orhun; Koylu, Bahadir; Selcukbiricik, Fatih; Bilgetekin, Irem; Helvaci, Kaan; Unal, Ahmet; Semiz, Huseyin Salih; Sakalar, Teoman; Sever, Nadiye; Cicek, Ceren Mordag; Dogu, Gamze Gokoz; Biter, Sedat; Bayram, Ertugrul; Yildiz, Canan; Demir, Hacer; Bayrakci, Ismail; Erdogan, Bulent; Kalender, Mehmet Emin; Guzel, Halil Goksel; Ozturk, Banu; Karabuga, Berkan; Ates, Ozturk; Cetin, Emine Bihter; Sahbazlar, Mustafa; Inal, Ali; Sunar, Veli; Basal, Fatma Bugdayci; Asik, Esra; Yildirim, Atila; Oksuz, Nejat Emre; Urun, Yuksel; Nayir, Erdinc; Turker, Sema; On, Sercan; Aytac, Ali; Menekse, Serkan; Temi, Yasemin Bakkal; Uygun, Kazim; Sahin, Elif; Keskinkilic, Merve; Arik, Zafer

Inflammatory and Nutritional Indices as Prognostic Markers in Locally Advanced Gastric Cancer Treated with Neoadjuvant FLOT: A Retrospective Multicenter Study

炎症和营养指标作为新辅助FLOT方案治疗局部晚期胃癌的预后标志物:一项回顾性多中心研究

Yolcu, Süleyman Tuna; Günaltılı, Murat; Yolcu, Emine Ayaz; Güzel, Süleyman Sami; Şengül, Nilay; Atcı, Muhammed Mustafa; Karaboyun, Kubilay; Erdem, Gökmen Umut; Alan, Özkan; Demirci, Nebi Serkan

Stage II colon cancer: does ChatGPT recommend more intensive adjuvant therapy? A comparison with MDT decisions

II期结肠癌:ChatGPT是否建议加强辅助治疗?与多学科团队(MDT)决策的比较

Birsin, Zeliha; Jeral, Seda; Cebeci, Selin; Çerme, Emir; Aliyev, Vali; Günaltılı, Murat; Abbasov, Hamza; Çiçek, Ebru; Demirci, Nebi Serkan; Alan, Özkan